Physician profile
Marisa Christopher
NPI 1699552547
$817.53
in general payments reported to CMS, 2019-2025
11 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $155 · 2024: $525 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800 · Education: $17.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.45 |
| Education | $17.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $167.82 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $151.33 | 2023-2024 | Dupixent |
| Axonics, INC. | $133.00 | 2024 | Axonics |
| Ardelyx, INC. | $122.08 | 2024 | Ibsrela |
| Aimmune Therapeutics, INC. | $93.12 | 2025 | Zenpep |
| Celltrion USA INC. | $47.50 | 2024-2025 | Vegzelma, Zymfentra |
| Genzyme Corporation | $30.07 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.17 | 2024 | Xifaxan |
| Enterra Medical, INC. | $17.16 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.99 | 2024 | Entyvio |
| Evoke Pharma, INC. | $14.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Christopher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.